🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Starting Proffered Paper 2! Come to exciting data! #ELCC2023 ESMO - Eur. Oncology Noemi Reguart #LCSM

Perhaps 2 other debates you don’t want to miss 👇 #ELIXR23 Patrick Forde M.Provencio Jonathan Spicer MD PhD Boris Sepesi MD FACS #PUgalde This friday in Montreal : vpsolution.tv/events/elixr/

Great discussion here in Montreal on early stage NSCLC: neoadjuvant, biomarkers, and - not surprisingly- still surgery! #ELIXR23

C’est avec tristesse que l'Institut Curie a appris le décès de Véronique Trillet-Lenoir. Le Pr Thierry Philip, président du Directoire, salue la mémoire de cette brillante cancérologue et députée européenne qui menait de grands combats autour de la santé partagés par l'Institut.

At ITMIG Society meeting, vibrant discussion of limitations of recent retrospective evaluation of consequences of thymectomy. Main focus on patients who had “thymectomy” without thymoma or MG. Clear consensus that THIS STUDY is NOT PRACTICE-CHANGING!

#ESMO23 Far more than a badge: a unique tool to learn more, discuss with colleagues, be a better oncologist, and improve the care of our patients with cancer. Welcome to Madrid!

Congratulations Nicolas Girard for this new standard of care for our EGFRex20ins NSCLC patients, a great step forward. Need to manage the skin tox with amivantamab ESMO - Eur. Oncology #ESMO2023

If you’re not using NGS- but some other technology- you won’t find EGFRex20ins pts. Now a big deal given we have a highly active 1st line drug option. Mutation detection technology matters

🚨 Presidential Session at #ESMO23 🚨 Prof. Nicolas Girard @Institut_Curie presented the results of the phase 3 study PAPILLON, showing superior efficacy of bispecific antibody + chemotherapy vs chemo alone in advanced #NSCLC with EGFR exon 20 insertions 👏👏 #LungCancer

Brava Marina Garassino !!! Thanks for your generosity and big heart ❤️! So happy to be part of this wonderful community!

What a truly memorable evening celebrating ‘what really counts’! …with unique hospitality by our dearest of friends 😘❤️🥂Marina Garassino

Welcome to #ESMO24 !

Great discussion on perioperative immunotherapy in NSCLC with the great David Harpole : answersincme.com/SVN #GetYourAnswersInCME #AiCME

Welcome to ESMO Sarcoma and Rare Cancer 2025 #esmorarecancers25

Do you want to learn about thymic tumors? Come to meet our outstanding faculty for #ELCC25 educational session!

📢 Update from #ELCC25! 📺 Prof. Nicolas Girard shares his views on the latest oncogene-addicted #NSCLC data presented at ELCC 2025 🤝 Programme endorsed by Exon 20 Group, a multistakeholder organization Biomarker Collaborative & ICAN, International Cancer Advocacy Network Supported by an Independent Educational Grant from Bayer #MedEd #Oncology

More patients cured with neoadjuvant immunotherapy: CheckMate-816 OS now in #NEJM #ASCO2025

Great #ASCO2025: eager to discuss all the new data at the VJ Oncology Post-ASCO Lung Cancer Highlights us06web.zoom.us/webinar/regist… with my friends Noemi Reguart Stephen V Liu, MD

#CIOT25 Discussion on targeted therapy with global experts Aɴᴛᴏɴɪᴏ Pᴀssᴀʀᴏ Lorenza Landi Nicolas Girard Tony Mok Alexander Drilon MD Ben Solomon - looking beyond the data, what outcomes are most important to our patients?

Honored to be member of the #fleischner society. Annual meeting in Rome.